Department of Pulmonary Diseases and Clinical Allergology, Sleep Research Center, University of Turku, Turku, Finland.
Department of Anesthesiology and Intensive Care, University of Turku, Turku, Finland.
Sleep Breath. 2024 Nov 27;29(1):13. doi: 10.1007/s11325-024-03164-4.
Obstructive sleep apnea (OSA) is a common disease in patients with coronary artery disease (CAD). Approximately 40-80% of cardiovascular disease patients have obstructive sleep apnea. The manifestation of it can vary significantly in different types of CAD patients. This systematic review and meta-analysis investigate the prevalence and severity of OSA in patients with acute coronary syndrome (ACS).
This systematic review was conducted according to PRISMA guidelines. The first inclusion criteria were that a reliable sleep study had to be done after treating the patients' acute coronary incident. All patients in the studies included were adults suffering from an ACS who underwent either coronary artery bypass grafting surgery (CABG), a percutaneous coronary intervention (PCI) or had no invasive coronary intervention done. A search was conducted within four valid databases 27.1.2023 and all suitable articles published after 1.1.2010 were included.
Eight studies fulfilled the full inclusion criteria. In five of them, a sleep study had been performed after PCI, in two after no coronary intervention, and in one study after CABG. Mean AHI in no-OSA group after PCI was 9.5 /h (95% CI 5.3-13.7) and in the no intervention group 6.4 /h (95% CI 3.5-9.4). In OSA patients, mean AHI after PCI was 34.9 /h (95% CI 25.9-43.8) vs. 24.1 /h without intervention (95% CI 15.6-32.6).
Sleep apnea is very common among ACS patients and should be screened for and addressed after the acute coronary intervention. Moreover, we found that OSA is more severe in patients in whom PCI for ACS was indicated as opposed to patients who underwent no coronary intervention.
阻塞性睡眠呼吸暂停(OSA)是冠心病(CAD)患者的常见疾病。大约 40-80%的心血管疾病患者患有阻塞性睡眠呼吸暂停。其表现因不同类型的 CAD 患者而有很大差异。本系统评价和荟萃分析旨在调查急性冠状动脉综合征(ACS)患者中阻塞性睡眠呼吸暂停的患病率和严重程度。
本系统评价按照 PRISMA 指南进行。第一个纳入标准是在治疗患者的急性冠状动脉事件后必须进行可靠的睡眠研究。所有纳入研究的患者均为接受冠状动脉旁路移植术(CABG)、经皮冠状动脉介入治疗(PCI)或未进行有创冠状动脉介入治疗的成人 ACS 患者。2023 年 2 月 27 日在四个有效数据库中进行了搜索,并纳入了自 2010 年 1 月 1 日以来发表的所有合适的文章。
八项研究完全符合纳入标准。其中五项研究在 PCI 后进行了睡眠研究,两项研究在无冠状动脉介入后进行了睡眠研究,一项研究在 CABG 后进行了睡眠研究。PCI 后无 OSA 组的平均 AHI 为 9.5 /h(95%CI 5.3-13.7),无干预组为 6.4 /h(95%CI 3.5-9.4)。在 OSA 患者中,PCI 后平均 AHI 为 34.9 /h(95%CI 25.9-43.8),无干预组为 24.1 /h(95%CI 15.6-32.6)。
睡眠呼吸暂停在 ACS 患者中非常常见,应在急性冠状动脉介入治疗后进行筛查和处理。此外,我们发现,与未进行冠状动脉干预的患者相比,提示 ACS 进行 PCI 的患者的 OSA 更为严重。